[Treatment of a hemorrhagic syndrome in severe von Willebrand disease in the presence of circulating anti-von-Willebrand-factor antibody].
D000328:Adult; D000941:Antigens / Q000032:analysis; D001132:Arm / Q000098:blood supply; D001241:Aspirin / Q000009:adverse effects; D005169:Factor VIII / Q000032:analysis; D005260:Female; D006406:Hematoma / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007518:Isoantibodies / Q000276:immunology*; D014842:von Willebrand Diseases / Q000150:complications* / Q000276:immunology / Q000628:therapy; D014841:von Willebrand Factor / Q000276:immunology / Q000627:therapeutic use*
D000941:Antigens; D007518:Isoantibodies; D014841:von Willebrand Factor; D005169:Factor VIII; D001241:Aspirin
Tratamiento de un síndrome hemorrágico en enfermedad de von Willebrand grave en presencia de un anticuerpo anti-factor von Willebrand circulante.